CHMP Backs Tenofovir Alafenamide (Vemlidy) for Chronic Hep B CHMP Backs Tenofovir Alafenamide (Vemlidy) for Chronic Hep B

Vemlidy has efficacy similar to that of tenofovir disoproxil (Viread), with fewer bone and renal side effects.International Approvals
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Infectious Diseases News Alert Source Type: news